These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17127248)

  • 21. Why is placentation abnormal in preeclampsia?
    Fisher SJ
    Am J Obstet Gynecol; 2015 Oct; 213(4 Suppl):S115-22. PubMed ID: 26428489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New insights in the pathophysiology of preeclampsia and potential therapeutic implications].
    Boulanger H; Flamant M
    Nephrol Ther; 2007 Dec; 3(7):437-48. PubMed ID: 18047998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxic trophoblast-derived sFlt-1 may contribute to endothelial dysfunction: implication for the mechanism of trophoblast-endothelial dysfunction in preeclampsia.
    Zhou Q; Qiao FY; Zhao C; Liu HY
    Cell Biol Int; 2011 Jan; 35(1):61-6. PubMed ID: 20828367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity.
    Palmer KR; Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Ye L; Binder N; Cannon P; Tuohey L; Johns TG; Shub A; Tong S
    Hypertension; 2015 Dec; 66(6):1251-9. PubMed ID: 26416849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Endothelial progenitor cells: new biomarkers and potential therapy in intensive care].
    Seguin T; Braun T; Mira JP
    Med Mal Infect; 2007 Jun; 37(6):305-11. PubMed ID: 17512151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exosomes From Women With Preeclampsia Induced Vascular Dysfunction by Delivering sFlt (Soluble Fms-Like Tyrosine Kinase)-1 and sEng (Soluble Endoglin) to Endothelial Cells.
    Chang X; Yao J; He Q; Liu M; Duan T; Wang K
    Hypertension; 2018 Dec; 72(6):1381-1390. PubMed ID: 30571229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered Endothelial Nitric Oxide Signaling as a Paradigm for Maternal Vascular Maladaptation in Preeclampsia.
    Osol G; Ko NL; Mandalà M
    Curr Hypertens Rep; 2017 Sep; 19(10):82. PubMed ID: 28942512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia.
    Silasi M; Cohen B; Karumanchi SA; Rana S
    Obstet Gynecol Clin North Am; 2010 Jun; 37(2):239-53. PubMed ID: 20685551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating endothelial cell number and markers of endothelial dysfunction in previously preeclamptic women.
    Tuzcu ZB; Asicioglu E; Sunbul M; Ozben B; Arikan H; Koc M
    Am J Obstet Gynecol; 2015 Oct; 213(4):533.e1-7. PubMed ID: 26116870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular biology of preeclampsia.
    Myatt L; Webster RP
    J Thromb Haemost; 2009 Mar; 7(3):375-84. PubMed ID: 19087223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelial progenitor cells: implications for cardiovascular disease.
    Möbius-Winkler S; Höllriegel R; Schuler G; Adams V
    Cytometry A; 2009 Jan; 75(1):25-37. PubMed ID: 19009636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating endothelial progenitor cells during human pregnancy.
    Sugawara J; Mitsui-Saito M; Hoshiai T; Hayashi C; Kimura Y; Okamura K
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1845-8. PubMed ID: 15585564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-eclampsia: clinical manifestations and molecular mechanisms.
    Baumwell S; Karumanchi SA
    Nephron Clin Pract; 2007; 106(2):c72-81. PubMed ID: 17570933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiogenic and antiangiogenic factors in preeclampsia.
    Helmo FR; Lopes AMM; Carneiro ACDM; Campos CG; Silva PB; Dos Reis Monteiro MLG; Rocha LP; Dos Reis MA; Etchebehere RM; Machado JR; Corrêa RRM
    Pathol Res Pract; 2018 Jan; 214(1):7-14. PubMed ID: 29174227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mechanisms of preeclampsia.
    Mutter WP; Karumanchi SA
    Microvasc Res; 2008 Jan; 75(1):1-8. PubMed ID: 17553534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Endothelial dysfunction: role in the maternal syndrome of preeclampsia and long-term consequences for the cardiovascular system].
    Calicchio R; Buffat C; Vaiman D; Miralles F
    Ann Cardiol Angeiol (Paris); 2013 Jun; 62(3):215-20. PubMed ID: 23721989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spreading endothelial cell dysfunction in response to necrotic trophoblasts. Soluble factors released from endothelial cells that have phagocytosed necrotic shed trophoblasts reduce the proliferation of additional endothelial cells.
    Chen Q; Ding JX; Liu B; Stone P; Feng YJ; Chamley L
    Placenta; 2010 Nov; 31(11):976-81. PubMed ID: 20880585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia.
    Maynard SE; Venkatesha S; Thadhani R; Karumanchi SA
    Pediatr Res; 2005 May; 57(5 Pt 2):1R-7R. PubMed ID: 15817508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preeclampsia: the role of persistent endothelial cells in uteroplacental arteries.
    Brosens I; Brosens JJ; Muter J; Puttemans P; Benagiano G
    Am J Obstet Gynecol; 2019 Sep; 221(3):219-226. PubMed ID: 30738027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial progenitor cell subsets and preeclampsia: Findings and controversies.
    Attar A; Monabati A; Parsanezhad ME
    J Chin Med Assoc; 2017 Oct; 80(10):615-622. PubMed ID: 28716604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.